Returns Chart

Mackenzie US Mid Cap Opportunities Series PWX (MFC8124) Total Return
Created with Highcharts 11.1.0Jul '24Oct '24Jan '25Apr '250.00%0.32%

Key Stats

Customize
Net Expense Ratio Total Assets Under Management Weighted Average Dividend Yield Turnover Ratio (Generic)
0.00% 1.866B 0.26% 14.70%
1 Year Fund Level Flows 1 Year Total Returns (Daily) Annualized Total Returns Since Inception (Daily) Max Drawdown (Since Inception)
-101.41M 0.32% Upgrade Upgrade

Basic Info

Investment Strategy
The Fund seeks to provide long-term capital growth and a reasonable rate of return by investing primarily in equity securities of mid-capitalization companies in the United States. The Fund will pursue this objective by investing in securities directly and/or by investing in other mutual funds. Any proposed change in the fundamental investment objectives of the Fund must be approved by a majority of votes cast at meeting of Fund investors called for that purpose.
General
Security Type Mutual Fund
Broad Asset Class US Equity
Broad Category Equity
Global Peer Group Equity US Sm&Mid Cap
Peer Group U.S. Small/Mid Cap Equity
Global Macro Equity North America
US Macro --
YCharts Categorization --
YCharts Benchmark --
Prospectus Objective --
Fund Owner Firm Name Mackenzie Investments
Broad Asset Class Benchmark Index
^SPTSX60TR 100.0%

View Basic Info
Start Trial

Net Fund Flows Versus Peer Group

View Net Fund Flows. Upgrade now.
1M
3M
6M
YTD
1Y
3Y
5Y
10Y
 
80.00B
60.00B
40.00B
20.00B
0
-20.00B
1 Month
% Rank: 83
-177.47M Peer Group Low
97.10M Peer Group High
1 Year
% Rank: 78
-101.41M
-558.69M Peer Group Low
532.93M Peer Group High
3 Months
% Rank: 82
-255.34M Peer Group Low
190.11M Peer Group High
3 Years
% Rank: 6
-1.301B Peer Group Low
711.12M Peer Group High
6 Months
% Rank: 65
-305.57M Peer Group Low
402.90M Peer Group High
5 Years
% Rank: 2
-1.598B Peer Group Low
1.465B Peer Group High
YTD
% Rank: 85
-418.24M Peer Group Low
255.72M Peer Group High
10 Years
% Rank: 2
-1.598B Peer Group Low
1.465B Peer Group High
Date Unavailable

Performance Versus Peer Group

 
20%
15%
10%
5%
0
Name
1M
3M
YTD
1Y
3Y
5Y
10Y
15Y
Total Return (NAV)
12.00%
12.00%
12.00%
12.00%
12.00%
12.00%
12.00%
12.00%
Peer Group Rtn. (NAV)
12.00%
12.00%
12.00%
12.00%
12.00%
12.00%
12.00%
12.00%
% Rank in Peer Group (NAV)
5.0
5.0
5.0
5.0
5.0
5.0
5.0
5.0
View Performance Versus Peer Group
Start Trial

Annual Total Returns Versus Peers

There are no valid items on this chart.

Name
2018
2019
2020
2021
2022
2023
2024
YTD
--
--
--
28.17%
-17.13%
13.93%
16.29%
-5.44%
-7.58%
21.93%
5.56%
28.04%
-6.24%
12.05%
21.04%
6.15%
--
--
--
26.12%
-25.08%
15.01%
5.55%
-4.72%
--
--
--
--
--
14.45%
6.08%
-3.13%
--
21.77%
13.00%
19.54%
-16.55%
7.82%
13.01%
-6.22%
8.68%
23.30%
20.64%
23.05%
-15.97%
19.07%
28.56%
0.05%
As of May 16, 2025.

Fundamentals

General
Distribution Yield --
Dividend Yield TTM (5-15-25) 0.00%
30-Day SEC Yield --
7-Day SEC Yield --
Stock
Weighted Average PE Ratio 37.28
Weighted Average Price to Sales Ratio 5.253
Weighted Average Price to Book Ratio 6.229
Weighted Median ROE 17.54%
Weighted Median ROA 7.11%
ROI (TTM) 9.85%
Return on Investment (TTM) 9.85%
Earning Yield 0.0346
LT Debt / Shareholders Equity 0.7618
As of January 31, 2025

Growth Metrics

EPS Growth (1Y) 27.64%
EPS Growth (3Y) 12.26%
EPS Growth (5Y) 13.14%
Sales Growth (1Y) 9.83%
Sales Growth (3Y) 11.76%
Sales Growth (5Y) 13.29%
Sales per Share Growth (1Y) 10.25%
Sales per Share Growth (3Y) 11.66%
Operating Cash Flow - Growth Ratge (3Y) 5.98%
As of January 31, 2025

Asset Allocation

Created with Highcharts 11.1.0
As of January 31, 2025.
Type % Net
Cash 3.41%
Stock 97.10%
Bond 0.00%
Convertible 0.00%
Preferred 0.00%
Other -0.51%
View Asset Allocation
Start Trial

Top 10 Holdings

Created with Highcharts 11.1.0
Name % Weight Price % Change
DexCom Inc 5.66% 85.71 0.05%
SS&C Technologies Holdings Inc 5.14% 79.78 0.34%
Akamai Technologies Inc 5.12% 77.69 1.54%
Vontier Corp 4.98% 37.01 0.49%
CoStar Group Inc 4.95% 77.12 1.41%
HealthEquity Inc 4.75% 98.60 0.97%
Cirrus Logic Inc 4.43% 106.54 -0.33%
Bio-Techne Corp 4.28% 49.04 1.66%
Keysight Technologies Inc 4.13% 165.42 0.39%
Charles River Laboratories International Inc 4.07% 141.82 2.11%

Fees & Availability

Fees
Actual 12B-1 Fee --
Actual Management Fee --
Administration Fee --
Maximum Front Load --
Maximum Deferred Load --
Maximum Redemption Fee --
General Availability
Available for Insurance Product --
Available for RRSP Yes
Purchase Details
Open to New Investors Yes
Minimum Initial Investment 100000.0 None
Minimum Subsequent Investment 50.00 None

Basic Info

Investment Strategy
The Fund seeks to provide long-term capital growth and a reasonable rate of return by investing primarily in equity securities of mid-capitalization companies in the United States. The Fund will pursue this objective by investing in securities directly and/or by investing in other mutual funds. Any proposed change in the fundamental investment objectives of the Fund must be approved by a majority of votes cast at meeting of Fund investors called for that purpose.
General
Security Type Mutual Fund
Broad Asset Class US Equity
Broad Category Equity
Global Peer Group Equity US Sm&Mid Cap
Peer Group U.S. Small/Mid Cap Equity
Global Macro Equity North America
US Macro --
YCharts Categorization --
YCharts Benchmark --
Prospectus Objective --
Fund Owner Firm Name Mackenzie Investments
Broad Asset Class Benchmark Index
^SPTSX60TR 100.0%

View Basic Info
Start Trial

Fundamentals

General
Distribution Yield --
Dividend Yield TTM (5-15-25) 0.00%
30-Day SEC Yield --
7-Day SEC Yield --
Stock
Weighted Average PE Ratio 37.28
Weighted Average Price to Sales Ratio 5.253
Weighted Average Price to Book Ratio 6.229
Weighted Median ROE 17.54%
Weighted Median ROA 7.11%
ROI (TTM) 9.85%
Return on Investment (TTM) 9.85%
Earning Yield 0.0346
LT Debt / Shareholders Equity 0.7618
As of January 31, 2025

Growth Metrics

EPS Growth (1Y) 27.64%
EPS Growth (3Y) 12.26%
EPS Growth (5Y) 13.14%
Sales Growth (1Y) 9.83%
Sales Growth (3Y) 11.76%
Sales Growth (5Y) 13.29%
Sales per Share Growth (1Y) 10.25%
Sales per Share Growth (3Y) 11.66%
Operating Cash Flow - Growth Ratge (3Y) 5.98%
As of January 31, 2025

Fund Details

Key Dates
Inception Date --
Last Annual Report Date 9/30/2023
Last Prospectus Date --
Share Classes
MFC8109 Commission-based Advice
MFC8112 Do-It-Yourself
MFC8113 Fee-based Advice
MFC8114 Fee-based Advice
MFC8115 Fee-based Advice
MFC8116 Fee-based Advice
MFC8117 Fee-based Advice
MFC8119 Commission-based Advice
MFC8120 Fee-based Advice
MFC8121 Fee-based Advice
MFC8122 Commission-based Advice
MFC8123 Commission-based Advice
MFC8125 Fee-based Advice
MFC8127 Commission-based Advice
MFC8131 Commission-based Advice
MFC9547 Commission-based Advice
MFC9548 Fee-based Advice
MFC9549 Fee-based Advice
MFC9550 Commission-based Advice
MFC9551 Commission-based Advice
MFC9552 Commission-based Advice
MRD293 Commission-based Advice
MRD793 Commission-based Advice
Attributes
Index Fund --
Inverse Fund --
Leveraged Fund --
Fund of Funds No
Currency Hedged Fund --
Synthetic Replication Fund No

Top Portfolio Holders

Name % Weight
Portfolio A 5.00%
Portfolio B 3.50%
Portfolio C 2.25%
View Top Portfolio Holders
Start Trial

Excel Add-In Codes

Name: =YCI("M:MFC8124.TO", "name")
Broad Asset Class: =YCI("M:MFC8124.TO", "broad_asset_class")
Broad Category: =YCI("M:MFC8124.TO", "broad_category_group")
Prospectus Objective: =YCI("M:MFC8124.TO", "prospectus_objective")
To find the codes for any of our securities and financial metrics, see our Complete Excel Reference.
View Excel Add-In Codes
Start Trial
Quickflows